ENTA insider buying & filings

ENTAENANTA PHARMACEUTICALS INC

NasdaqGS · Healthcare · $377.47M

$12.96

+2.05% · Sep 11

37 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Aug 10 · scanned 5m ago

Price · 1Y · dailyNo open-market activity in range

▸ hover a marker for the filing · drag to zoom

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Market cap

$377.47M

Float

22.5M

77% public

Short % float

Pro

Price / profit

—

not yet profitable

Price / future profit

—

Price / sales

5.8

Institutional stakes

▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing

1 filingnewest first

13G/AFarallon Capital Management, L.l.c.8.3%Aug 14

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Aug 10TAXRottinghaus Scott T.Chief Medical Officerdirect1,467 @ $13.34$19.6K

Feb 13TAXKowalsky Matthew PaulChief Legal Officerdirect1,902 @ $14.25$27.1K

Feb 13GRANTKowalsky Matthew PaulChief Legal Officerdirect4,175 sh—

Feb 13GRANTKowalsky Matthew PaulChief Legal Officerdirect1,318 sh—

Feb 13TAXLuu BrendanChief Business Officerdirect3,257 @ $14.25$46.4K

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice